AsthmaBrain Status
The company received an undisclosed amount of development capital from Muir Equity in 2015.
Developer of application to predict and prevent asthma attacks by using historical and perpetual analysis of patient populations to identify asthma-related risks. The company's Neural Intelligence Systems (NIS) enable payors, providers and patients to predict and prevent asthma attacks, simply and organically, using real-time data, unique deep learning technology and automated alerts.
Year Founded
2015
General Information
-
Website
-
Business Status
Generating Revenue
-
Ownership Status
Privately Held (backing)
-
Financing Status
Private Equity-Backed
AsthmaBrain News and Updates
3 Health Conditions That Stormy Weather Can Make Worse
Health Essentials from Cleveland Clinic | January 25, 2021
Andrea Hanneman on mindbodygreen
mindbodygreen.com | December 29, 2020
New federal grant boosts clinical trial access for Louisiana's children - News
News-Medical.Net | December 5, 2020
More opportunities from Burlington’s Christmas Cheer
Burlington Times News | November 23, 2020
Study reveals key role of IL-33 signaling molecule in parasite infections, other health conditions - News
News-Medical.Net | November 15, 2020
Shepherd's Purse: Benefits, Side Effects, and Preparations
Verywell Health | November 13, 2020
AsthmaBrain's Verticals
AsthmaBrain Primary Industry Sector / Group / Code
AsthmaBrain's Trends
Headquarters
-
HQ Address Line 11311 Sutter Street
-
HQ Address Line 2Suite 202
-
HQ CitySan Francisco
-
HQ State/ProvinceCalifornia
-
HQ Post Code94109
-
HQ CountryUnited States
AsthmaBrain's Keywords
mood_badFeed is empty.
Add a review